Q2N0S6 (Q2N0S6_9HIV1) Human immunodeficiency virus 1
Envelope glycoprotein gp160 UniProtKBInterProInteractive Modelling
860 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
159 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Cytoplasmic tail deleted HIV-1 Env bound with three 4E10 Fabs |
Heteromer | 6×NAG; 3×NAG; 36×NAG; | ||||
Assess | ||||||
Cytoplasmic tail deleted HIV Env trimer in nanodisc |
Heteromer | 6×NAG; 3×NAG; 36×NAG; | ||||
Assess | ||||||
Crystal Structure at 3.7 A Resolution of Fully Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion… |
Heteromer | 6×NAG; 9×NAG; 3×NAG; 3×NAG; 9×NAG; 12×NAG; 6×NAG; 3×NAG; 3×NAG; 12×NAG; | ||||
Assess | ||||||
3.5 Angstrom Crystal Structure of a Fully and Natively Glycosylated BG505 SOSIP.664 HIV-1 Env Trime… |
Heteromer | 3×NAG; 6×NAG; 12×NAG; 3×NAG; 6×NAG; 3×NAG; 6×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 6×NAG; | ||||
Assess | ||||||
Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer in Complex with V3 Loop-targeting A… |
Heteromer | 3×NAG; 3×NAG; 21×NAG; 3×NAG; 6×NAG; 3×NAG; 3×NAG; 24×NAG; | ||||
Assess | ||||||
Crystal structure BG505 SOSIP gp140 HIV-1 Env trimer bound to broadly neutralizing antibodies PGT12… |
Heteromer P01834; P01857; S6B291; | 12×NAG; 6×NAG; 3×NAG; 3×NAG; 3×NAG; 9×NAG; 3×NAG; 3×NAG; 18×NAG; 3×SO4; | ||||
Assess | ||||||
Cryo-EM structure of M4008_N1 Fab in complex with BG505 DS-SOSIP.664 Env trimer |
Heteromer | 3×NAG; 15×NAG; 15×NAG; 3×NAG; 21×NAG; | ||||
Assess | ||||||
Cryo-EM structure of vaccine-elicited antibody 0PV-c.01 in complex with HIV-1 Env BG505 DS-SOSIP an… |
Heteromer | 15×NAG; 9×NAG; 6×NAG; 12×NAG; 3×NAG; 3×NAG; 9×NAG; | ||||
Assess | ||||||
BG505 SOSIP.v5.2.N241.N289 in complex with rhesus macaque Fab RM19R |
Heteromer | 18×NAG; 3×NAG; 3×NAG; 39×NAG; | ||||
Assess | ||||||
Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch bNAb 10-1074 |
Heteromer | 4×NAG; 3×NAG; 2×NAG; 12×NAG; 30×NAG; | ||||
Assess | ||||||
Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab87… |
Heteromer | 3×NAG; 3×NAG; 3×NAG; 18×NAG; 21×NAG; | ||||
Assess | ||||||
BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-2 from animal Rh.33311 (Wk26 tim… |
Heteromer | 9×NAG; 2×NAG; 1×NAG; 47×NAG; | ||||
Assess | ||||||
Cryo-EM structure of vFP49.02 Fab in complex with HIV-1 Env BG505 DS-SOSIP.664 (conformation 3) |
Heteromer | 21×NAG; 12×NAG; 3×NAG; 3×NAG; 15×NAG; | ||||
Assess | ||||||
Cryo-EM structure of vFP49.02 Fab in complex with HIV-1 Env BG505 DS-SOSIP.664 (conformation 1) |
Heteromer | 21×NAG; 12×NAG; 3×NAG; 3×NAG; 15×NAG; | ||||
Assess | ||||||
Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody A12V163-a.01 in complex with HIV… |
Heteromer | 21×NAG; 6×NAG; 6×NAG; 9×NAG; 9×NAG; | ||||
Assess | ||||||
Cryo-EM structure of vFP49.02 Fab in complex with HIV-1 Env BG505 DS-SOSIP.664 (conformation 2) |
Heteromer | 24×NAG; 12×NAG; 3×NAG; 15×NAG; | ||||
Assess | ||||||
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP1 |
Heteromer | 3×NAG; 49×NAG; | ||||
Assess | ||||||
BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-1 from animal Rh.33311 (Wk26 tim… |
Heteromer | 9×NAG; 1×NAG; 2×NAG; 54×NAG; | ||||
Assess | ||||||
Cryo-EM structure of vaccine-elicited antibody 0PV-a.01 in complex with HIV-1 Env BG505 DS-SOSIP an… |
Heteromer | 12×NAG; 18×NAG; 6×NAG; 6×NAG; 3×NAG; 3×NAG; 9×NAG; | ||||
Assess | ||||||
Cryo-EM structure of vaccine-elicited antibody 0PV-b.01 in complex with HIV-1 Env BG505 DS-SOSIP an… |
Heteromer | 21×NAG; 9×NAG; 9×NAG; 3×NAG; 3×NAG; 12×NAG; | ||||
Assess | ||||||
The CryoEM structure of N49-P9.6-FR3 and PGT121 Fabs in complex with BG505 SOSIP.664 |
Heteromer | 21×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 15×NAG; | ||||
Assess | ||||||
Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody vFP1.01 in complex with HIV-1 En… |
Heteromer | 9×NAG; 9×NAG; 15×NAG; 3×NAG; 3×NAG; 3×NAG; 9×NAG; | ||||
Assess | ||||||
Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab27… |
Heteromer | 16×NAG; 2×NAG; 4×NAG; 29×NAG; | ||||
Assess | ||||||
Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab89… |
Heteromer | 16×NAG; 10×NAG; 2×NAG; 1×NAG; 22×NAG; | ||||
Assess | ||||||
Cryo-EM structure of a BG505 Env-sCD4-17b-8ANC195 complex |
Heteromer P01730; | 3×NAG; 6×NAG; | ||||
Assess | ||||||
Crystal Structure at 3.7 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env T… |
Heteromer | 6×NAG; 12×NAG; 6×NAG; 6×NAG; 3×NAG; 6×NAG; 9×NAG; | ||||
Assess | ||||||
Crystal structure of BG505-SOSIP.v4.1-GT1-N137A in complex with Fabs 35022 and 9H/109L |
Heteromer | 3×NAG; 3×NAG; 3×NAG; 3×NAG; 9×NAG; 3×NAG; 12×NAG; | ||||
Assess | ||||||
Crystal structure of the cleavage-independent prefusion HIV Env glycoprotein trimer of the clade A … |
Heteromer | 3×NAG; 6×NAG; 9×NAG; 6×NAG; 9×NAG; 3×NAG; 3×MAN; 3×BMA; 36×NAG; 6×MAN; | ||||
Assess | ||||||
Structure of the BG505 SOSIP.664 trimer in complex with neutralizing antibody Fab fragments 10-1074… |
Heteromer | 1×NAG; 3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×NAG; 2×MAN; 2×NAG; 1×NAG; 1×NAG; 1×NAG; 1×NAG; 3×NAG; 1×FUC; | ||||
Assess | ||||||
HIV gp140 trimer MD39-10MUTA in complex with Fabs PGT124 and 35022 |
Heteromer | 6×NAG; 12×NAG; 3×NAG; 6×NAG; 3×NAG; 21×NAG; | ||||
Assess | ||||||
HIV-1 Env BG505 SOSIP.664 H72C-H564C trimer in complex with bNAbs PGT122 Fab, 35O22 Fab and NIH45-4… |
Heteromer | 9×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 33×NAG; | ||||
Assess | ||||||
Cryo-EM structure of HIV-1 BG505 DS-SOSIP ENV trimer bound to VRC34.01-MM28 FAB |
Heteromer | 18×NAG; 3×NAG; 3×NAG; 21×NAG; | ||||
Assess | ||||||
HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 |
Heteromer Q6PJF2; Q8N355; S6B2B6; S6C4S0; | 7×NAG; 3×NAG; 2×NAG; 2×NAG; 1×NAG; 27×NAG; | ||||
Assess | ||||||
BG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibodies 3BNC117 and PGT145 |
Heteromer | 28×NAG; 5×NAG; 1×NAG; 3×NAG; 3×NAG; 3×NAG; 20×NAG; | ||||
Assess | ||||||
Cryo-EM structure of HIV-1 BG505 DS-SOSIP ENV trimer bound to VRC34.01 FAB |
Heteromer | 24×NAG; 3×NAG; 3×NAG; 15×NAG; | ||||
Assess | ||||||
Structure of Bispecific CAP256V2LS-J3 Fab in complex with BG505 DS-SOSIP.664 |
Heteromer | 8×NAG; 22×NAG; 6×NAG; 5×NAG; 25×NAG; | ||||
Assess | ||||||
BG505 SOSIP.v5.2 in complex with rabbit Fab 43A2 |
Heteromer | 18×NAG; 3×NAG; 27×NAG; | ||||
Assess | ||||||
Cryo-EM structure of HIV-1 BG505 DS-SOSIP ENV trimer bound to VRC34.01-COMBO1 FAB |
Heteromer | 24×NAG; 3×NAG; 3×NAG; 15×NAG; | ||||
Assess | ||||||
HIV-1 Env (BG505 SOSIP.664) in complex with the IgA bNAb 7-269 and the antibody 3BNC117. |
Heteromer | 19×NAG; 3×NAG; 5×NAG; 10×NAG; 3×NAG; 1×NAG; 3×NAG; 20×NAG; | ||||
Assess | ||||||
Cryo-EM structure of SHIV-elicited RHA1.V2.01 in complex with HIV-1 Env BG505 DS-SOSIP.664 |
Heteromer | 10×NAG; 4×NAG; 1×NAG; 2×NAG; 1×NAG; 40×NAG; | ||||
Assess | ||||||
BG505 SOSIP.664 Trimer |
Heteromer | 12×NAG; 3×NAG; 6×NAG; 3×NAG; 3×NAG; 33×NAG; | ||||
Assess | ||||||
BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-8 from animal Rh.33311 (Wk26 tim… |
Heteromer | 7×NAG; 3×NAG; 52×NAG; | ||||
Assess | ||||||
Cryo-EM structure of llama J3 VHH antibody in complex with HIV-1 Env BG505 DS-SOSIP.664 |
Heteromer | 6×NAG; 15×NAG; 6×NAG; 33×NAG; | ||||
Assess | ||||||
BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-7 from animal Rh.33311 (Wk26 tim… |
Heteromer | 18×NAG; 2×NAG; 1×NAG; 1×NAG; 39×NAG; | ||||
Assess | ||||||
BG505 SOSIP.v5.2 in complex with VRC40.01 and RM19R Fabs |
Heteromer | 30×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 18×NAG; | ||||
Assess | ||||||
BG505.MD39TS Env trimer in complex with Fab from antibody C05 |
Heteromer | 21×NAG; 1×BMA; 3×NAG; 1×NAG; 41×NAG; | ||||
Assess | ||||||
BG505 SOSIP.664 trimer in complex with broadly neutralizing HIV antibody 3BNC117 |
Heteromer | 3×NAG; 24×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 21×NAG; | ||||
Assess | ||||||
Cryo-EM Structure of PG9RSH DU025 Fab in complex with BG505 DS-SOSIP.664 |
Heteromer | 17×NAG; 2×NAG; 3×NAG; 1×NAG; 40×NAG; | ||||
Assess | ||||||
BJOX2000.664 trimer in complex with Fab fragment of broadly neutralizing HIV antibody PGT145 |
Heteromer | 25×NAG; 5×NAG; 1×NAG; 3×NAG; 2×NAG; 1×NAG; 20×NAG; | ||||
Assess | ||||||
CNE55.664 trimer in complex with broadly neutralizing HIV antibody PGT145 |
Heteromer | 25×NAG; 5×NAG; 1×NAG; 3×NAG; 2×NAG; 1×NAG; 20×NAG; | ||||
Assess | ||||||
Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry… |
Heteromer | 3×NAG; 6×NAG; 9×NAG; 3×NAG; 36×NAG; 3×83G; | ||||
Assess | ||||||
Crystal Structure of HIV-1 BG505 DS-SOSIP.3mut Prefusion Env Trimer in Complex with Human Antibodie… |
Heteromer | 6×NAG; 15×NAG; 3×NAG; 3×NAG; 3×NAG; 18×NAG; | ||||
Assess | ||||||
Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry… |
Heteromer | 4×NAG; 1×NAG; 2×NAG; 1×NAG; 11×NAG; 1×JYJ; | ||||
Assess | ||||||
Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry… |
Heteromer | 3×NAG; 6×NAG; 9×NAG; 3×NAG; 36×NAG; 3×JYY; | ||||
Assess | ||||||
Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry… |
Heteromer | 3×NAG; 6×NAG; 12×NAG; 3×NAG; 30×NAG; 3×JYV; | ||||
Assess | ||||||
Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to CH31 scFv in Complex with … |
Heteromer | 3×NAG; 15×NAG; 3×NAG; 3×NAG; 3×NAG; 21×NAG; | ||||
Assess | ||||||
Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to N6 FR3-03 scFv in Complex … |
Heteromer | 3×NAG; 21×NAG; 3×NAG; 3×NAG; 3×NAG; 21×NAG; | ||||
Assess | ||||||
Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to VRC01 FR3-03 scFv in Compl… |
Heteromer | 3×NAG; 21×NAG; 3×NAG; 3×NAG; 3×NAG; 15×NAG; | ||||
Assess | ||||||
Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry… |
Heteromer | 3×NAG; 6×NAG; 9×NAG; 3×NAG; 33×NAG; 3×JYS; | ||||
Assess | ||||||
Crystal structure of 8ANC195 Fab in complex with BG505 SOSIP.664 HIV-1 Env trimer |
Heteromer | 2×NAG; 5×NAG; 3×NAG; 2×NAG; 2×NAG; 2×NAG; 6×NAG; | ||||
Assess | ||||||
3.9 Angstrom Crystal Structure of a Fully and Natively Glycosylated BG505 SOSIP.664 HIV-1 Env Trime… |
Heteromer | 3×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 9×NAG; 6×NAG; 3×NAG; 3×NAG; 3×NAG; 6×NAG; 3×NAG; 3×NAG; | ||||
Assess | ||||||
Crystal Structure of the BG505 SOSIP gp140 HIV-1 Env trimer in Complex with the Broadly Neutralizin… |
Heteromer S6B291; | 9×NAG; 3×NAG; 18×NAG; 6×NAG; 3×NAG; 3×NAG; 18×NAG; | ||||
Assess | ||||||
Crystal Structure of HIV-1 BG505 SOSIPv8 Trimer in Complex with CD4bs targeting antibody 21N13 and … |
Heteromer | 6×NAG; 6×NAG; 3×NAG; 12×NAG; 3×NAG; 18×NAG; | ||||
Assess | ||||||
Crystal structure of the BG505 triple tandem trimer gp140 HIV-1 Env in complex with PGT124 and 35O22 |
Heteromer | 1×NAG; 14×NAG; 6×NAG; 3×NAG; 2×NAG; 31×NAG; | ||||
Assess | ||||||
Uncleaved prefusion optimized gp140 trimer with an engineered 10-residue HR1 turn bound to broadly … |
Heteromer | 9×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 15×NAG; 3×NAG; 3×NAG; 6×NAG; | ||||
Assess | ||||||
Uncleaved prefusion optimized gp140 trimer with an engineered 8-residue HR1 turn bound to broadly n… |
Heteromer | 12×NAG; 6×NAG; 3×NAG; 6×NAG; 9×NAG; 3×NAG; 3×NAG; 12×NAG; | ||||
Assess | ||||||
Cryo-EM Structure of PG9RSH DU011 Fab in complex with BG505 DS-SOSIP.664 |
Heteromer A4F255; Q6PJG0; | 16×NAG; 3×NAG; 3×NAG; 1×NAG; 38×NAG; | ||||
Assess | ||||||
BG505 SOSIP.v5.2(7S) in complex with the monoclonal antibodies Rh.33172 mAb.1 and RM19R |
Heteromer | 3×NAG; 12×NAG; 51×NAG; | ||||
Assess | ||||||
Cryo-EM structure of VRC01.23 in complex with HIV-1 Env BG505 DS.SOSIP |
Heteromer | 9×NAG; 3×NAG; 6×NAG; 3×NAG; 3×NAG; 36×NAG; | ||||
Assess | ||||||
BG505 MD64 N332-GT5 SOSIP trimer in complex with BG18-like precursor HMP42 fragmentantigen binding … |
Heteromer | 15×NAG; 3×NAG; 39×NAG; | ||||
Assess | ||||||
BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-2 from animal Rh.32034 (Wk26 time point) |
Heteromer | 33×NAG; 1×NAG; 3×NAG; 2×NAG; 13×NAG; | ||||
Assess | ||||||
BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-2 from animal Rh.33104 (Wk26 time point) |
Heteromer | 25×NAG; 3×NAG; 29×NAG; | ||||
Assess | ||||||
BG505 SOSIP reconstructed from a designed nanoparticle, BG505 SOSIP-T33-31 (Component B) |
Heteromer | 3×NAG; 21×NAG; 39×NAG; | ||||
Assess | ||||||
BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-3 from animal Rh.32034 (Wk26 time point) |
Heteromer | 26×NAG; 2×NAG; 1×NAG; 27×NAG; | ||||
Assess | ||||||
BG505 MD64 N332-GT5 SOSIP trimer in complex with BG18-like precursor HMP1 fragmentantigen binding a… |
Heteromer | 15×NAG; 3×NAG; 3×NAG; 33×NAG; | ||||
Assess | ||||||
BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-4 from animal Rh.32034 (Wk26 time point) |
Heteromer | 34×NAG; 3×NAG; 17×NAG; | ||||
Assess | ||||||
BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-4 from animal Rh.33311 (Wk26 tim… |
Heteromer | 20×NAG; 1×NAG; 2×NAG; 42×NAG; | ||||
Assess | ||||||
BG505 SOSIP.664 in complex with broadly neutralizing antibodies PG9 and 8ANC195 |
Heteromer P0DOX5; Q6GMW3; Q8TCD0; S6B291; | |||||
Assess | ||||||
Cryo-EM structure of HIV-1 Env(BG505.T332N SOSIP) in complex with DH1030.1 Fab |
Heteromer | 3×NAG; 5×NAG; 6×NAG; 1×NAG; 33×NAG; | ||||
Assess | ||||||
BG505 SOSIP MD39 in complex with the monoclonal antibodies Rh.33104 mAb.1 and RM20A3 |
Heteromer | 8×NAG; 1×NAG; 12×NAG; | ||||
Assess | ||||||
BG505 SOSIP reconstructed from a designed nanoparticle, BG505 SOSIP-T33-31 (Component A) |
Heteromer | 3×NAG; 24×NAG; 39×NAG; | ||||
Assess | ||||||
Cryo-EM Structure of PGT145 DU303 Fab in complex with BG505 DS-SOSIP.664 |
Heteromer | 14×NAG; 4×NAG; 5×NAG; 35×NAG; | ||||
Assess | ||||||
BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-1 from animal Rh.33172 (Wk38 time poin… |
Heteromer | 3×NAG; 18×NAG; 44×NAG; | ||||
Assess | ||||||
BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-1 from animal Rh.32034 (Wk26 time point) |
Heteromer | 30×NAG; 3×NAG; 24×NAG; | ||||
Assess | ||||||
BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-3 from animal Rh.33104 (Wk26 time point) |
Heteromer | 36×NAG; 2×NAG; 4×NAG; 17×NAG; | ||||
Assess | ||||||
Cryo-EM structure of PGT128 Fab in complex with BG505 SOSIP.664 Env trimer |
Heteromer | 18×NAG; 21×NAG; 6×NAG; 3×NAG; 3×NAG; 9×NAG; | ||||
Assess | ||||||
BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 |
Heteromer P01834; Q8TCD0; S6B291; | 10×NAG; 18×NAG; 5×NAG; 3×NAG; 7×NAG; 1×NAG; 13×NAG; | ||||
Assess | ||||||
Initial contact of HIV-1 Env with CD4: Cryo-EM structure of BG505 DS-SOSIP trimer in complex with C… |
Heteromer P01730; | |||||
Assess | ||||||
Crystal Structure of a Stabilized DS-SOSIP.6mut BG505 gp140 HIV-1 Env Trimer, Containing Mutations … |
Heteromer | 6×NAG; 3×NAG; 27×NAG; 3×NAG; 3×NAG; 21×NAG; | ||||
Assess | ||||||
Crystal structure of broadly neutralizing antibody N49P6 Fab in complex with HIV-1 BG505 SOSIP.664 … |
Heteromer | 9×NAG; 21×NAG; 3×NAG; 3×NAG; 21×NAG; | ||||
Assess | ||||||
Crystal structure of bovine Fab NC-Cow1 in complex with HIV-1 BG505 SOSIP.664, and human Fabs 35022… |
Heteromer | 3×NAG; 6×NAG; 9×NAG; 9×NAG; 12×NAG; 6×NAG; | ||||
Assess | ||||||
vFP52.02 Fab in complex with BG505 DS-SOSIP Env trimer |
Heteromer | 3×NAG; 12×NAG; 2×NAG; 4×NAG; 35×NAG; | ||||
Assess | ||||||
BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-4 from animal Rh.33104 (Wk26 time point) |
Heteromer | 31×NAG; 3×NAG; 1×NAG; 20×NAG; | ||||
Assess | ||||||
BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-3 from animal Rh.33311 (Wk26 tim… |
Heteromer | 1×NAG; 5×NAG; 2×NAG; 57×NAG; | ||||
Assess | ||||||
BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-5 from animal Rh.33311 (Wk26 tim… |
Heteromer | 10×NAG; 3×NAG; 45×NAG; | ||||
Assess | ||||||
Ab1245 Fab in complex with BG505 SOSIP.664 and 8ANC195 Fab |
Heteromer | 21×NAG; 1×NAG; 1×NAG; 1×NAG; 2×NAG; 2×NAG; 4×NAG; 23×NAG; | ||||
Assess | ||||||
vFP48.02 Fab in complex with BG505 DS-SOSIP Env trimer |
Heteromer | 9×NAG; 9×NAG; 3×NAG; 36×NAG; | ||||
Assess | ||||||
BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-1 from animal Rh.33104 (Wk26 time point) |
Heteromer | 30×NAG; 1×NAG; 2×NAG; 23×NAG; | ||||
Assess | ||||||
BG505 SOSIP.v5.2 in complex with the monoclonal antibody Rh4O9.8 (as Fab fragment) |
Heteromer | 16×NAG; 1×NAG; 3×NAG; 31×NAG; | ||||
Assess | ||||||
HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 |
Heteromer Q6PIL8; Q8N355; S6B2B6; | 3×NAG; 18×NAG; 6×NAG; 6×NAG; 3×NAG; 9×NAG; 15×NAG; | ||||
Assess | ||||||
The HIV-1 Envelope Glycoprotein Clone BG505 SOSIP.664 in Complex with Three Copies of the Bovine Br… |
Heteromer | 24×NAG; 6×NAG; 36×NAG; | ||||
Assess | ||||||
BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-4 from animal Rh.33172 (Wk38 time poin… |
Heteromer | 3×NAG; 24×NAG; 1×NAG; 37×NAG; | ||||
Assess | ||||||
BG505 SOSIP.664 in complex with the V3-targeting rhesus macaque antibody 1485 and human gp120-gp41 … |
Heteromer | 1×NAG; 1×NAG; 3×NAG; 2×NAG; 1×NAG; 2×NAG; 8×NAG; 2×NAG; 3×NAG; 1×NAG; 34×NAG; | ||||
Assess | ||||||
Crystal Structure of a Stabilized DS-SOSIP.mut4 BG505 gp140 HIV-1 Env Trimer, Containing Mutations … |
Heteromer | 6×NAG; 3×NAG; 3×NAG; 27×NAG; 3×NAG; 24×NAG; | ||||
Assess | ||||||
BG505 SOSIP.v5.2 in complex with rhesus macaque Fab RM20E1 and PGT122 Fab |
Heteromer | 8×NAG; 4×NAG; 2×NAG; 3×NAG; 2×NAG; 24×NAG; | ||||
Assess | ||||||
BG505 SOSIP.v4.1 in complex with rhesus macaque Fab RM20F |
Heteromer | 6×NAG; 27×NAG; 21×NAG; | ||||
Assess | ||||||
BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-2 from animal Rh.33172 (Wk38 time poin… |
Heteromer | 3×NAG; 11×NAG; 49×NAG; | ||||
Assess | ||||||
Cryo-EM model of HIV-1 Env BG505 SOSIP.664 in complex with rabbit monoclonal antibody 11B fragment … |
Heteromer | 9×NAG; 3×NAG; 36×NAG; | ||||
Assess | ||||||
BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-3 from animal Rh.33172 (Wk38 time poin… |
Heteromer | 3×NAG; 22×NAG; 39×NAG; | ||||
Assess | ||||||
BG505 SOSIP.v5.2 in complex with rhesus macaque Fab RM20J |
Heteromer | 21×NAG; 3×NAG; 3×NAG; 18×NAG; | ||||
Assess | ||||||
Asymmetrically open conformational state (Class II) of HIV-1 Env trimer BG505 SOSIP.664 in complex … |
Heteromer P01730; | 2×NAG; 3×NAG; 24×NAG; | ||||
Assess | ||||||
Cryo-EM structure of CD4bs antibody Ab1303 in complex with HIV-1 Env trimer BG505 SOSIP.664 |
Heteromer | 1×NAG; 4×NAG; 6×NAG; 5×NAG; 8×NAG; 1×MAN; | ||||
Assess | ||||||
BG505 SOSIP.664 with 2G12 Fab2 |
Heteromer | 3×NAG; 6×NAG; 6×NAG; 3×NAG; 3×NAG; 9×NAG; 21×NAG; | ||||
Assess | ||||||
HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and partially deglycosylate… |
Heteromer | 12×NAG; 3×NAG; 51×NAG; | ||||
Assess | ||||||
Structure of CD4 mimetic M48U1 in complex with BG505 SOSIP.664 HIV-1 Env trimer and 17b Fab |
Heteromer | 1×NAG; 1×NAG; 1×NAG; 8×NAG; | ||||
Assess | ||||||
HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in stable CHO cells in complex with RM20A3 Fab |
Heteromer | 12×NAG; 3×NAG; 51×NAG; | ||||
Assess | ||||||
HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and deglycosylated by endog… |
Heteromer | 12×NAG; 3×NAG; 51×NAG; | ||||
Assess | ||||||
Asymmetrically open conformational state (Class I) of HIV-1 Env trimer BG505 SOSIP.664 in complex w… |
Heteromer P01730; | 4×NAG; 2×NAG; 1×NAG; 21×NAG; | ||||
Assess | ||||||
HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293S cells in complex with RM20A3 Fab |
Heteromer | 12×NAG; 3×NAG; 51×NAG; | ||||
Assess | ||||||
HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293F cells in complex with RM20A3 Fab |
Heteromer | 12×NAG; 3×NAG; 51×NAG; | ||||
Assess | ||||||
Structure of CD4 mimetic BNM-III-170 in complex with BG505 SOSIP.664 HIV-1 Env trimer and 17b Fab |
Heteromer | 7×NAG; 1×NAG; 1×NAG; 1×NAG; 27×NAG; 3×5VG; | ||||
Assess | ||||||
Cryo-EM model of HIV-1 Env BG505 SOSIP.664 in complex with rabbit monoclonal antibody 10A fragment … |
Heteromer | 3×NAG; 9×NAG; 33×NAG; | ||||
Assess | ||||||
Cryo-EM model of HIV-1 Env BG505 SOSIP.664 in complex with rabbit monoclonal antibody 11A fragment … |
Heteromer | 12×NAG; 3×NAG; 27×NAG; | ||||
Assess | ||||||
Structure of HIV-1 BG505 SOSIP-HT2 in complex with two CD4 molecules (class I) |
Heteromer P01730; Q2N0S5; | 4×NAG; 4×NAG; 1×NAG; 7×NAG; | ||||
Assess | ||||||
Cryo-EM structure of BG505 SOSIP HIV-1 Env trimer in complex with CD4 receptor (D1D2) and broadly n… |
Heteromer P01730; | 2×NAG; 8×NAG; 11×NAG; 1×NAG; 30×NAG; | ||||
Assess | ||||||
HIV Env BG505 NFL TD+ in complex with antibody E70 fragment antigen binding |
Heteromer | 12×NAG; 3×NAG; 3×NAG; 27×NAG; | ||||
Assess | ||||||
Crystal Structure of the BG505 SOSIP gp140 HIV-1 Env trimer in Complex with an early putative precu… |
Heteromer | 1×NAG; 6×NAG; 1×NAG; 1×NAG; 1×NAG; 1×NAG; 3×NAG; 1×MAN; | ||||
Assess | ||||||
XFEL crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex … |
Heteromer Q2N0S5; | 3×NAG; 3×NAG; 3×NAG; 9×NAG; 3×NAG; 9×NAG; 6×NAG; 3×NAG; 3×NAG; 9×NAG; | ||||
Assess | ||||||
Crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with … |
Heteromer Q2N0S5; | 6×NAG; 12×NAG; 9×NAG; 9×NAG; 6×NAG; 3×NAG; 3×NAG; 12×NAG; | ||||
Assess | ||||||
Crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with … |
Heteromer Q2N0S5; | |||||
Assess | ||||||
Antibody vFP53.02 in complex with HIV-1 envelope trimer BG505 DS-SOSIP |
Heteromer Q2N0S7; | 9×NAG; 6×NAG; 24×NAG; 3×NAG; 21×NAG; | ||||
Assess | ||||||
HIV Env BG505 SOSIP with polyclonal Fabs from immunized rabbit #3417 post-boost#1 |
Heteromer A0A1Y1B8B1; P01840; Q2N0S7; | 3×NAG; 21×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 21×NAG; | ||||
Assess | ||||||
Cryo-EM structure of BG505 DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibo… |
Heteromer Q2N0S7; | 21×NAG; 3×NAG; 6×NAG; 3×NAG; 12×NAG; | ||||
Assess | ||||||
Vaccine-elicited human antibody 2C09 in complex with HIV-1 envelope trimer BG505 DS-SOSIP |
Heteromer Q2N0S7; | 3×NAG; 36×NAG; 3×NAG; 3×NAG; 15×NAG; | ||||
Assess | ||||||
Vaccine-elicited human antibody 2C06 in complex with HIV-1 envelope trimer BG505 DS-SOSIP |
Heteromer Q2N0S7; | 4×NAG; 36×NAG; 1×NAG; 2×NAG; 12×NAG; | ||||
Assess | ||||||
Cryo-EM structure of BG505 DS-SOSIP in complex with glycan276-dependent broadly neutralizing antibo… |
Heteromer Q2N0S7; | 27×NAG; 3×NAG; 9×NAG; | ||||
Assess | ||||||
Backbone model based on cryo-EM map at 8.5 A of domain-swapped, glycan-reactive, neutralizing antib… |
Heteromer Q2N0S9; | 9×MAN; 3×NAG; 6×NAG; 3×NAG; | ||||
Assess | ||||||
Cryo-EM structure at 3.2 A resolution of HIV-1 fusion peptide-directed antibody, A12V163-b.01, elic… |
Heteromer Q2N0S7; | 21×NAG; 9×NAG; 3×NAG; 6×NAG; 3×NAG; 12×NAG; | ||||
Assess | ||||||
Cryo-EM structure at 3.8 A resolution of HIV-1 fusion peptide-directed antibody, DF1W-a.01, elicite… |
Heteromer Q2N0S7; | 8×NAG; 12×NAG; 7×NAG; 12×NAG; 3×NAG; 9×NAG; | ||||
Assess | ||||||
Cryo-EM structure at 4.0 A resolution of vaccine-elicited antibody vFP7.04 in complex with HIV-1 En… |
Heteromer Q2N0S7; | 21×NAG; 9×NAG; 6×NAG; 3×NAG; 3×NAG; | ||||
Assess | ||||||
Cryo-EM structure at 4.2 A resolution of vaccine-elicited antibody DFPH-a.15 in complex with HIV-1 … |
Heteromer Q2N0S7; | 21×NAG; 9×NAG; 3×NAG; 3×NAG; 3×NAG; 9×NAG; | ||||
Assess | ||||||
Crystal Structure at 4.3 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env T… |
Heteromer P01857; P04578; P0DOY2; | 6×NAG; 3×NAG; 3×NAG; 24×NAG; 3×NAG; 3×NAG; 3×NAG; 18×NAG; 3×SO4; | ||||
Assess | ||||||
Cryo-EM structure of BG505 SOSIP.664 HIV-1 Env trimer in complex with temsavir, 8ANC195, and 10-1074 |
Heteromer Q2N0S5; | 33×NAG; 3×NAG; 3×NAG; 3×NAG; 21×NAG; 3×83J; | ||||
Assess | ||||||
VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure |
Heteromer P0DOX5; Q2N0S7; Q6N089; Q6P5S8; Q8N5F4; | 27×NAG; 3×NAG; 3×NAG; 3×NAG; 21×NAG; | ||||
Assess | ||||||
HIV-1 Envelope Glycoprotein Clone BG505 delCT N332T in complex with broadly neutralizing antibody F… |
Heteromer Q2N0S7; | 22×NAG; 1×NAG; 2×NAG; 1×NAG; 2×NAG; 1×NAG; 1×NAG; 1×NAG; 22×NAG; | ||||
Assess | ||||||
Cryo-EM structure of BG505.SOSIP.664 in complex with BF520.1 antigen binding fragment |
Heteromer Q2N0S7; | 18×NAG; 21×NAG; 6×NAG; 3×NAG; 3×NAG; 9×NAG; | ||||
Assess | ||||||
VRC01 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure |
Heteromer Q2N0S9; Q6N095; Q6PIL8; | 3×NAG; 21×NAG; 12×NAG; 15×NAG; | ||||
Assess | ||||||
Crystal structure of 438-B11 Fab in complex with an uncleaved prefusion optimized (UFO) soluble BG5… |
Heteromer Q2N0S9; | 15×NAG; 3×NAG; 12×NAG; 6×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 24×NAG; | ||||
Assess | ||||||
Crystal structure of antibody 438-B11 DSS mutant (Cys98A-100aA) in complex with an uncleaved prefus… |
Heteromer Q2N0S9; | 3×NAG; 3×NAG; 3×NAG; 36×NAG; | ||||
Assess | ||||||
BG505 MD39 SOSIP trimer in complex with mature BG18 fragment antigen binding |
Heteromer Q2N0S8; | 3×NAG; 15×NAG; 6×NAG; 3×NAG; 3×NAG; 18×NAG; | ||||
Assess | ||||||
BG505 MD64 N332-GT2 SOSIP trimer in complex with germline-reverted BG18 fragment antigen binding |
Heteromer Q2N0S5; | 18×NAG; 3×NAG; 3×NAG; 18×NAG; | ||||
Assess | ||||||
Crystal Structure of the BG505 SOSIP gp140 HIV-1 Env trimer in Complex with the Broadly Neutralizin… |
Heteromer | 12×NAG; 3×NAG; 3×MAN; 30×NAG; | ||||
Assess | ||||||
Cryo-EM structure of the BG505 SOSIP.664 HIV-1 Env trimer with 3 PGV04 Fabs |
Heteromer | |||||
Assess | ||||||
cryoEM reconstruction of the HIV gp140 in complex with the extracellular domains of CD4 and the adn… |
Heteromer P01730; | |||||
Assess | ||||||
Crystal structure of BG505 SOSIP.v4.1-GT1.2 trimer in complex with gl-PGV20 and PGT124 Fabs |
Heteromer | 4×NAG; 9×NAG; 1×NAG; 1×NAG; 1×NAG; 1×MAN; 30×NAG; | ||||
Assess | ||||||
Cryo-EM structure of HIV-1 Env trimer BG505 SOSIP.664 in complex with CD4bs antibody Ab1573 |
Heteromer A0A6H1VH54; | 1×NAG; 3×NAG; 1×NAG; 5×NAG; | ||||
Assess | ||||||
Cryo-EM structure of HIV-1 Env CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 |
Heteromer A0A1W6IPB2; | 27×NAG; 9×NAG; 3×NAG; 18×NAG; | ||||
Assess | ||||||
ApexGT5 in complex with GT5-d42.16 and RM20A3 Fabs |
Heteromer | 10×NAG; 3×NAG; 2×NAG; 1×NAG; 3×NAG; 3×NAG; 41×NAG; | ||||
Assess | ||||||
Crystal Structure of Ligand-Free BG505 SOSIP.664 HIV-1 Env Trimer | homo-6-mer | 3×NAG; 6×NAG; 45×NAG; | ||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
7n6u.1.A | homo-3-mer | 0.59 | 1×NAG; | 76.22 | ||
Assess |